If your oldest share is since 2014, then in that case you should be winning as we speak unless you bout at that peak in 2015 which does not sound the case. So, given this is spec then on top of that this is biotech and given the repetitive trend that is so predictable then one should be encouraged to be patient ... otherwise they should consider short term trading ... which I myself am against as a matter of principle when it comes to biotech, since and medicine or genuine technology start ups ... because this should at the end of the day be public investment.
Ann: Immutep Capital Raising Presentation, page-187
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.020(6.67%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.3¢ | 30.0¢ | $1.040M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 42705 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |